 |
|
 |
|
| |
Advancing Cell Biology: Understanding the Cell Through New Technologies
Event Date: October 1, 2009 12:00 p.m. Eastern Time; 9:00 a.m. Pacific Time; 4 p.m. GMT
Brought to you by the Science/AAAS Business Office
|
| |
Real Player | | | Real Media Video (56k/150k) | | |
Windows Media Player | | | Windows Media Video (56k/150k) |
|
| |
|
|
| |
In recent years, cell biology has enjoyed rapid growth and has gained critical attention in academia and industry. Advances in cellular analysis technologies such as microscopy, cytometry, and high content analysis are having profound effects on the fields of stem cells, cancer research, immunology, and drug discovery. As cellular analysis becomes more sophisticated and makes use of less invasive methods and more label-free, higher throughput and multiplexing capabilities, scientists are faced with new opportunities as well as new challenges. In this webinar, our panel of experts will talk about the rapidly changing face of cell biology, exploring how today's advances will shape tomorrow's discoveries.
During this webinar our panelists will:
- discuss the current state of cell biology research
- look at how new technologies are changing and enabling discoveries
- examine current and future challenges, such as problems associated with difficult-to-handle cell lines
- answer your questions live!
|
|
| |
Speakers:
 |
James F. Leary, Ph.D.
Purdue University
West Lafayette, IN
Professor James F. Leary's research and teaching career spans more than 30 years. His original training includes an aerospace engineering degree from Massachusetts Institute for Technology, postgraduate work in space physics, and a Ph.D. in Biophysics from Penn State University with a postdoctoral fellowship at Los Alamos National Laboratory. Prior to 1995, Prof. Leary was an Assistant and Associate Professor of Experimental Pathology at the University of Rochester Medical School, before becoming a tenured Professor of Internal Medicine (Division of Infectious Diseases), Pathology, Biophysics, Microbiology & Immunology, and Human Biological Chemistry & Genetics, as well as an Assistant Director of the Biomedical Engineering Center at the University of Texas Medical Branch in Galveston. In 2005, Prof. Leary moved to Purdue University and became the School of Veterinary Medicine Endowed Professor of Nanomedicine and a tenured full professor in the Department of Basic Medical Sciences and the Weldon School of Biomedical Engineering. Prof. Leary’s current research involves the development of new, high throughput technologies for genomics, proteomics, drug discovery, and stem cell isolation and manipulation, utilizing microfluidics as well as the development of smart nanoengineered systems for single-cell drug/gene delivery for nanomedicine. He is the holder of eight U.S. patents, with four currently pending and is the author of numerous papers in the fields of high throughput technologies, minimal residual disease monitoring, developmental immunology, cancer research, and nanomedicine. Recently he was elected a Fellow of the AIMBE (American Institute for Medical and Biological Engineering), the highest honorary for biomedical engineers in the United States, for his pioneering work in high-speed flow cytometry and cell sorting. |
 |
Marcie Glicksman, Ph.D.
Harvard Center for Neurodiscovery
Boston, MA
Dr. Marcie Glicksman received her Bachelor’s degree from Brown University in Providence, Rhode Island and her Ph.D. in neuroscience from Washington University in St. Louis, Missouri. Dr. Glicksman has been in the field of drug discovery for 18 years, the most recent five in academics and thirteen years in the pharmaceutical/biotech industry, having worked at Cephalon, DuPont-Merck, Cubist (as director of leads discovery), and the start up company, Descartes Therapeutics. She is currently the senior director of the leads discovery group at the Laboratory for Drug Discovery in Neurodegeneration, which is part of the Harvard NeuroDiscovery Center, and assistant professor in the Neurology Department at Brigham and Women’s Hospital and Harvard Medical School. Dr. Glicksman was elected in 2005 to the board of directors for the Society for Biomolecular Sciences and served as its chairperson for two years. She is on the science advisory board for the Alzheimer’s disease foundation (ADDF/ISOA) and the California Institute for Regenerative Medicine (CIRM), and reviews grants for NIH and the Michael J. Fox Foundation. She has extensive experience in assay development, high throughput screening, and chemical databases as well as animal pharmacology and preclinical development.
|
 |
Lars J. Brandén, Ph.D.
Director Center for High Throughput Cell Biology
Yale University, CT
Dr. Lars Brandén received his undergraduate degree in molecular genetics from the University of Lund, Sweden, and completed his doctoral studies in cell and molecular biology at the Karolinska Institutet, Stockholm, Sweden, under the guidance of Professor C.I. Edvard Smith. He pursued a postdoctoral research fellowship in the Laboratory of Cellular Biochemistry & Biophysics at the Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center in New York. Dr. Brandén currently serves as the Director of the Yale Center for High Throughput Cell Biology.
|
|
|
| |
Moderator: Sean Sanders, Ph.D., Commercial Editor, Science/AAAS
 |
Sean Sanders did his undergraduate training at the University of Cape Town, South Africa, and his Ph.D. at the University of Cambridge, UK, supported by the Wellcome Trust. Following postdoctoral training at the National Institutes of Health and Georgetown University, Dr. Sanders joined TranXenoGen, a startup biotechnology company in Massachusetts working on avian transgenics. Pursuing his parallel passion for writing and editing, Dr. Sanders joined BioTechniques as an editor, before joining Science/AAAS in 2006. Currently Dr. Sanders is the Worldwide Commercial Editor for the journal Science and Program Director for Outreach.
|
|
|
|
| |
___________________________________________________________________________________________________
|
 |
|
| |
For the best experience we recommend you use Internet Explorer 6 (IE6) or higher on a Windows-based PC to view this webinar. Please ensure that you are using a computer with a stable internet connection and good bandwidth. To ensure the best possible performance of the webinar we recommend that you avoid using a dial-up connection. Note: please confirm the start time of the webinar in your time zone. A free time zone converter is available at www.timeanddate.com/worldclock/converter.html
|
| |
Test Your System
|
| | Help |
| |
Download Real Player
|
| |
Download Windows Media Player
|
| |
|
|
|